Successful Rate of Glaucoma Surgery in Secondary Glaucoma after Vitrectomy in Kariadi General Hospital Semarang 2020-2022 Oral Presentation - Observational Study - Resident
Article Sidebar
-
Secondary Glaucoma, Trabeculectomy, GDD Implant
Abstract
Introduction & Objectives
Glaucoma is one of the most frequent complications of vitrectomy surgery. It can cause a significant
rise in intraocular pressure (IOP). Glaucoma surgery can be planned in medically uncontrolled
glaucoma. Trabeculectomy and Glaucoma Drainage Device (GDD) implantation are the most
frequent filtering surgeries used in these cases. This study aims to define the success rate of
glaucoma surgery in secondary glaucoma after vitrectomy.
Methods
This study is an analytical observational study with retrospective data collection held from medical
records of patients with secondary glaucoma after vitrectomy who underwent glaucoma surgery in
Kariadi General Hospital Semarang from 2020-2022. Surgical success defined by postoperative IOP
reduced by>20% from baseline, with or without anti-glaucoma medication.
Results
There were 16 eyes of trabeculectomy with 5-fluorouracil (5-FU), and 8 eyes of GDD implants. The
mean preoperative IOP was 43.76+6.77 mmhg for trabeculectomy 5-FU, and 42.43+4.02 mmhg for
GDD implant. IOP levels in both groups varied significantly after one day, one week, one month, and
three months after surgery (p<0.05). The success rate for the trabeculectomy 5-FU group was
81.25% and the GDD implant group was 87.5% in 3 months. There was no statistically significant
difference in the success rate between the trabeculectomy 5-FU and GDD implant groups (p=0.839).
The complication for the GDD implant group was 25%. No complications were found in the
trabeculectomy 5-FU group.
Conclusion
There was no significant difference in the success rate between trabeculectomy 5-FU and the GDD
implant group. Both groups are viable for glaucoma surgery in secondary glaucoma after vitrectomy
surgery.
Full text article
References
Mowatt L. Secondary glaucoma after vitreoretinal procedures. Glaucoma - Current Clinical and Research Aspects.2011:11(11):361-372 2. Kolipaka GP, Rao A. Secondary glaucoma following vitreo-retinal surgeries. Indian J Ophthalmol 2022;71:18-25.
Cornacel C, et al. Surgical Treatment in Silicone Oil-Associated Glaucoma. Diagnostics. 2022:12(1005):1-11
Pillai G, Varkey R, Unnikrishnan U, Radhakrishnan N. Incidence and risk factors for intraocular pressure rise after transconjunctival vitrectomy. Original Article. 2020 May 1, 2020;68(5):812-7.
Maulida F, Rahmi FL, Cahyono M. Success rate of trabeculectomy in secondary glaucoma after vitrectomy in Kariadi Hospital, Semarang, Central Java. Ophthalmol Ina 2021;47(2):73-78
Perpusatakaan RSM Cicendo. Characteristic secondary glaucoma after pars plana vitrectomy surgery in rhegmatogenous retinal detachment patients in Cicendo Hospital in January-June 2020 [Internet]. 2020 [cited 2023 Mei 10].Avalaiblefrom:https://perpustakaanrsmcicen do.com
Liu Z, Fu G, Liu AJE, medicine t. The relationship between inflammatory mediator expression in the aqueous humor and secondary glaucoma incidence after silicone oil tamponade. 2017;14(6):5833-6.
Xu P, Xia T, Chen JJJCEO. Early Postoperative Intraocular Pressure Elevation after Vitreoretinal Surgery. 2017;8(636):2.
Bhoot M, Agarwal A, Dubey S, Pegu J, Gandhi M. Silicone Oil Induced Glaucoma. Delhi J Ophthalmol. 2018;29;9-13
Singh D, Chandra A, Sihota R, Kumar S, Gupta V. Long-term success of mitomycin-augmented trabeculectomy for glaucoma after vitreoretinal surgery with silicone oil insertion: a prospective case series. Retina. 2014 Jan;34(1):123-8
Tanna A, Boland M, Giaconi J, et al. Surgical Therapy for Glaucoma. In: Tanna A, Boland M, Giaconi J, editors. Glaucoma Basic Clinical Science Course. San Fransisco: American Academy of Ophthalmology; 2022. p. 256-75.
Authors
Copyright (c) 2023 Nur Azizah Intan Putri Ismail, Maharani, Fifin L. Rahmi, Denti Puspasari
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
